The Ninth Circuit will hear arguments from L’Oreal and a plaintiff who alleges the firm’s RevitaLift products are unlawfully marketed drugs, following the case’s dismissal in July on federal preemption grounds. At the same time, Biersdorf intends to seek summary judgment in five-year-old litigation for a similar design concerning Nivea Skin Firming Hydration Body Lotion in a California district. To help better understand the background and implications of both cases, HBW covers details about the basis of claims by the plaintiffs and the legal reasons for each of the courts’ findings to date. The report goes on to forecast the potential resolutions of both suits.